There are many cases of “cancer” in our life. In fact, cancer is not a real source of disease, nor is it as terrible as we think. Cancer cells are produced in our body every moment, and cancer cells are equivalent to reactionaries, while our immune system is equivalent to guards. However, when the body suffers from more serious damage to the immune system, such as physical rays, cancer-causing chemicals, etc., cancer cells cannot be removed in time. Cancer cells cannot be removed in time, they will proliferate and form tumors, invading and destroying our normal tissues and organs. Moreover, cancer cells can penetrate from the tumor and enter the blood or lymphatic system, which is how cancer can go from the original site to other organs to form new tumors, this process is called cancer metastasis, most cancers are named according to the organ or cell type they start from, for example, cancer cells originate from Most cancers are named according to their starting organ or cell type, for example, cancer cells that originate from the prostate tissue itself are called prostate cancer in situ and those that originate from other tissues are called prostate metastatic cancer. There is a great imbalance in the distribution of prostate cancer incidence in all regions of the world, with the difference between the highest and lowest incidence regions being more than 25 times, with the highest incidence rates in developed countries and regions such as Oceania, Western Europe, Northern Europe, and North America, and the lowest in South Central Asia. China is one of the countries with a low incidence of prostate cancer, with a WHO standard rate of 1.84/100,000, much lower than the world average of 8.20/100,000. At the same time, the natural history of prostate cancer is the most unique of all organ malignancies, varying from person to person, unlike other organ malignancies that end in a sinister outcome. Most prostate cancer patients have tumors that can remain latent for a long time or even go undetected for life. Some studies show that 33% of men have prostate cancer as a result of autopsy, yet only 1% die as a result. However, it is worth noting that with the advent of an aging society in China and changes in diet and living environment, the incidence of prostate cancer in China has been on the rise in the last 20 years. The early screening technology for prostate cancer has not been widely promoted in China, resulting in most prostate cancer patients being detected only when they visit the doctor due to late symptoms such as urinary tract symptoms and bone pain, resulting in missing the best time for treatment and a poor prognosis. Early detection of prostate cancer is especially important, and some studies show that the 10-year survival rate of patients with early stage prostate cancer can be over 95% if they receive timely radical treatment. So how can we achieve early detection of prostate cancer? Prostate rectal examination, serum prostate-specific antigen test and transrectal prostate ultrasound are currently recognized as the best methods for early detection of prostate cancer. Among them, serum prostate-specific antigen (PSA), as a specific marker for prostate cancer, has a specificity of 90% to 97% for the diagnosis of prostate cancer. It is considered to be the most valuable tumor marker for prostate cancer and is widely used for screening, diagnosis and post-treatment monitoring of prostate cancer. Age and genetic factors have an important influence on the occurrence of prostate cancer, the older you are, the more likely it is that prostate cancer will occur, so it is recommended that men over the age of 50 should be screened regularly every year, and men with a family history of prostate cancer should be screened earlier than 45 years old. In Chinese medicine, from a holistic viewpoint, it is believed that the development of prostate cancer is a contradictory struggle between the damage of the evil and the resistance of the positive energy. The process of prostate cancer development is the process of the weakness of the body’s positive qi and the gradual invasion of the evil qi by the deficiency. Although there is no record of prostate cancer in Chinese medicine, it is classified as “gonorrhea”, “blood in urine”, “accumulation”, and “Y obstruction” according to clinical manifestations and signs. “It has its own characteristics in treating prostate cancer. According to the different stages of prostate cancer, the treatment of prostate cancer can be effective through the methods of consolidation, heart adjustment, tonification, warming of yang, and tongli. Patients with prostate cancer often have low immune function, and treatment by applying the Chinese medicine Fu Zheng Pei Ben method can indeed partially improve the thalamus-pituitary-adrenal cortex function of patients, which can partially reduce the side effects of radiotherapy and chemotherapy and protect the bone marrow hematopoietic function. For patients with advanced prostate cancer, although Fu Zheng Pei Ben Chinese medicine cannot cure the tumor, it can partially improve patients’ clinical symptoms, improve their quality of life and truly survive with cancer. The incidence of prostate cancer in China is significantly lower than the world average, and the death rate of prostate cancer is lower than that of most other cancers. There are tumor markers with high diagnostic specificity for prostate cancer, which allows for early detection of prostate cancer. In terms of treatment, we have the advantage of Chinese medicine, which, when combined with modern medical treatments, can significantly improve the quality of life and prolong the survival time of patients. Therefore, we say that prostate cancer is not as scary as we think.